ECB-ART-52837
Int J Mol Sci
2020 Nov 07;2121:. doi: 10.3390/ijms21218364.
Show Gene links
Show Anatomy links
Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection.
Festa M
,
Sansone C
,
Brunet C
,
Crocetta F
,
Di Paola L
,
Lombardo M
,
Bruno A
,
Noonan DM
,
Albini A
.
???displayArticle.abstract???
Growing interest in hypertension-one of the main factors characterizing the cardiometabolic syndrome (CMS)-and anti-hypertensive drugs raised from the emergence of a new coronavirus, SARS-CoV-2, responsible for the COVID19 pandemic. The virus SARS-CoV-2 employs the Angiotensin-converting enzyme 2 (ACE2), a component of the RAAS (Renin-Angiotensin-Aldosterone System) system, as a receptor for entry into the cells. Several classes of synthetic drugs are available for hypertension, rarely associated with severe or mild adverse effects. New natural compounds, such as peptides, might be useful to treat some hypertensive patients. The main feature of ACE inhibitory peptides is the location of the hydrophobic residue, usually Proline, at the C-terminus. Some already known bioactive peptides derived from marine resources have potential ACE inhibitory activity and can be considered therapeutic agents to treat hypertension. Peptides isolated from marine vertebrates, invertebrates, seaweeds, or sea microorganisms displayed important biological activities to treat hypertensive patients. Here, we reviewed the anti-hypertensive activities of bioactive molecules isolated/extracted from marine organisms and discussed the associated molecular mechanisms involved. We also examined ACE2 modulation in sight of SARS2-Cov infection prevention.
???displayArticle.pubmedLink??? 33171852
???displayArticle.link??? Int J Mol Sci
???displayArticle.grants??? [+]
PG/2018/0494374 "Antitumor Drugs and Vaccines from the Sea (ADViSE)", COVID-2020-12371849 Ministero della Salute (MoH)
References [+] :
Abachi,
Antihypertensive and Angiotensin-I-Converting Enzyme (ACE)-Inhibitory Peptides from Fish as Potential Cardioprotective Compounds.
2019, Pubmed
Abachi, Antihypertensive and Angiotensin-I-Converting Enzyme (ACE)-Inhibitory Peptides from Fish as Potential Cardioprotective Compounds. 2019, Pubmed
Admassu, Bioactive Peptides Derived from Seaweed Protein and Their Health Benefits: Antihypertensive, Antioxidant, and Antidiabetic Properties. 2018, Pubmed
Albini, The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. 2020, Pubmed
Aluko, Antihypertensive peptides from food proteins. 2015, Pubmed
Andersen, The proximal origin of SARS-CoV-2. 2020, Pubmed
Angeli, Hypertension, inflammation and atrial fibrillation. 2014, Pubmed
Atanasov, Discovery and resupply of pharmacologically active plant-derived natural products: A review. 2015, Pubmed
Baci, Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis. 2020, Pubmed
Barbosa, Structure and function of a novel antioxidant peptide from the skin of tropical frogs. 2018, Pubmed
Barnett, DPP-4 inhibitors and their potential role in the management of type 2 diabetes. 2006, Pubmed
Berry, Catabolism in chronic heart failure. 2000, Pubmed
Brown, Lactic Acid Bacteria as Cell Factories for the Generation of Bioactive Peptides. 2017, Pubmed
Burrell, Myocardial infarction increases ACE2 expression in rat and humans. 2005, Pubmed
Caci, COVID-19 and Obesity: Dangerous Liaisons. 2020, Pubmed
Cardin, Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. 2003, Pubmed
Chamsi-Pasha, Angiotensin-converting enzyme 2 as a therapeutic target for heart failure. 2014, Pubmed
Chen, Processing Optimization and Characterization of Angiotensin-Ι-Converting Enzyme Inhibitory Peptides from Lizardfish (Synodus macrops) Scale Gelatin. 2018, Pubmed
Chen, Comparison of an angiotensin-I-converting enzyme inhibitory peptide from tilapia (Oreochromis niloticus) with captopril: inhibition kinetics, in vivo effect, simulated gastrointestinal digestion and a molecular docking study. 2020, Pubmed
Cheon, The ubiquitin proteasome pathway in neuropsychiatric disorders. 2019, Pubmed
Chobanian, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. 2003, Pubmed
Chockalingam, Worldwide epidemic of hypertension. 2006, Pubmed
Cian, Antithrombotic Activity of Brewers' Spent Grain Peptides and their Effects on Blood Coagulation Pathways. 2018, Pubmed
Crackower, Angiotensin-converting enzyme 2 is an essential regulator of heart function. 2002, Pubmed
Dales, Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. 2002, Pubmed
Daliri, Bioactive Peptides. 2017, Pubmed
Daskaya-Dikmen, Angiotensin-I-Converting Enzyme (ACE)-Inhibitory Peptides from Plants. 2017, Pubmed
De Miguel, Inflammation and hypertension: new understandings and potential therapeutic targets. 2015, Pubmed
Díez-Freire, ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. 2006, Pubmed
Donoghue, A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. 2000, Pubmed
Drapala, Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins. 2014, Pubmed
Evans, Ischemia reperfusion injury provokes adverse left ventricular remodeling in dysferlin-deficient hearts through a pathway that involves TIRAP dependent signaling. 2020, Pubmed
Fang, Structural and molecular basis of angiotensin-converting enzyme by computational modeling: Insights into the mechanisms of different inhibitors. 2019, Pubmed
Ferrario, Cardiac remodelling and RAS inhibition. 2016, Pubmed
Ferrario, Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. 2005, Pubmed
Fitzgerald, Isolation and characterization of bioactive pro-peptides with in vitro renin inhibitory activities from the macroalga Palmaria palmata. 2012, Pubmed
Fujita, LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein. 1999, Pubmed
Furuta, Angiotensin I Converting Enzyme Inhibitory Peptides Derived from Phycobiliproteins of Dulse Palmaria palmata. 2016, Pubmed
Gallagher, Regulation of ACE2 in cardiac myocytes and fibroblasts. 2008, Pubmed
Giles, Expanding the definition and classification of hypertension. 2005, Pubmed
Goette, EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. 2016, Pubmed
Grant, Drugs from the sea--fact or fantasy? 1977, Pubmed
Grobe, Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). 2007, Pubmed
He, Pilot and plant scaled production of ACE inhibitory hydrolysates from Acetes chinensis and its in vivo antihypertensive effect. 2008, Pubmed
Hernández-Ledesma, Antihypertensive peptides: production, bioavailability and incorporation into foods. 2011, Pubmed
Hoffmann, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. 2020, Pubmed
Huentelman, Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor. 2004, Pubmed
Huertas, Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? 2020, Pubmed
Isah, Stress and defense responses in plant secondary metabolites production. 2019, Pubmed
Ishiyama, Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. 2004, Pubmed
Iwata, Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme. 2009, Pubmed
Kaur, Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. 2018, Pubmed
Kawasaki, Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. 2000, Pubmed
Kim, Effects of ACE2 inhibition in the post-myocardial infarction heart. 2010, Pubmed
Ko, Purification and determination of two novel antioxidant peptides from flounder fish (Paralichthys olivaceus) using digestive proteases. 2013, Pubmed
Kohama, Isolation of angiotensin-converting enzyme inhibitor from tuna muscle. 1988, Pubmed
Kuba, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. 2005, Pubmed
Lautié, Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes. 2020, Pubmed
Lee, Antihypertensive peptides from animal products, marine organisms, and plants. 2017, Pubmed
Li, Novel Natural Angiotensin Converting Enzyme (ACE)-Inhibitory Peptides Derived from Sea Cucumber-Modified Hydrolysates by Adding Exogenous Proline and a Study of Their Structure⁻Activity Relationship. 2018, Pubmed , Echinobase
Lin, Anti-Inflammatory and Analgesic Effects of the Marine-Derived Compound Excavatolide B Isolated from the Culture-Type Formosan Gorgonian Briareum excavatum. 2015, Pubmed
Lindequist, Marine-Derived Pharmaceuticals - Challenges and Opportunities. 2016, Pubmed
Liu, Purification, Characterization and Evaluation of Inhibitory Mechanism of ACE Inhibitory Peptides from Pearl Oyster (Pinctada fucata martensii) Meat Protein Hydrolysate. 2019, Pubmed
Liu, Recurrence of the world's largest green-tide in 2009 in Yellow Sea, China: Porphyra yezoensis aquaculture rafts confirmed as nursery for macroalgal blooms. 2010, Pubmed
Malve, Exploring the ocean for new drug developments: Marine pharmacology. 2016, Pubmed
Manoharan, STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS. 2017, Pubmed
Martínez-Maqueda, Antihypertensive peptides from food proteins: a review. 2012, Pubmed
Matsufuji, Antihypertensive effects of angiotensin fragments in SHR. 1995, Pubmed
Matyas, Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. 2021, Pubmed
Minkiewicz, BIOPEP-UWM Database of Bioactive Peptides: Current Opportunities. 2019, Pubmed
Mirzaei, Production of antioxidant and ACE-inhibitory peptides from Kluyveromyces marxianus protein hydrolysates: Purification and molecular docking. 2018, Pubmed
Mourad, Interaction between RAAS inhibitors and ACE2 in the context of COVID-19. 2020, Pubmed
Nakamura, Relationship between urinary sodium excretion and pioglitazone-induced edema. 2010, Pubmed
Ngo, Active peptides from skate (Okamejei kenojei) skin gelatin diminish angiotensin-I converting enzyme activity and intracellular free radical-mediated oxidation. 2014, Pubmed
Nguyen, Hypertension management: an update. 2010, Pubmed
Ni, Inhibition mechanism and model of an angiotensin I-converting enzyme (ACE)-inhibitory hexapeptide from yeast (Saccharomyces cerevisiae). 2012, Pubmed
Nielsen, Milk bioactive peptide database: A comprehensive database of milk protein-derived bioactive peptides and novel visualization. 2017, Pubmed
Nii, Determination of antihypertensive peptides from an izumi shrimp hydrolysate. 2008, Pubmed
Ocaranza, Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. 2006, Pubmed
Oscar, The Tropical Invasive Seagrass, Halophila stipulacea, Has a Superior Ability to Tolerate Dynamic Changes in Salinity Levels Compared to Its Freshwater Relative, Vallisneria americana. 2018, Pubmed
Pangestuti, Bioactive Peptide of Marine Origin for the Prevention and Treatment of Non-Communicable Diseases. 2017, Pubmed
Patel, From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension. 2014, Pubmed
Pinzi, Molecular Docking: Shifting Paradigms in Drug Discovery. 2019, Pubmed
Pujiastuti, Marine Organisms as Potential Sources of Bioactive Peptides that Inhibit the Activity of Angiotensin I-Converting Enzyme: A Review. 2019, Pubmed
Qian, Antihypertensive effect of angiotensin i converting enzyme-inhibitory peptide from hydrolysates of Bigeye tuna dark muscle, Thunnus obesus. 2007, Pubmed
Rabelo, Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress. 2016, Pubmed
Rella, Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors. 2006, Pubmed
Rentzsch, Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. 2008, Pubmed
Schirone, A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling. 2017, Pubmed
Soro-Paavonen, Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. 2012, Pubmed
Suetsuna, Antihypertensive effects of Undaria pinnatifida (wakame) peptide on blood pressure in spontaneously hypertensive rats. 2004, Pubmed
Sun, Separation and Characterization of Angiotensin I Converting Enzyme (ACE) Inhibitory Peptides from Saurida elongata Proteins Hydrolysate by IMAC-Ni2. 2017, Pubmed
Sun, Purification of Antioxidant Peptides by High Resolution Mass Spectrometry from Simulated Gastrointestinal Digestion Hydrolysates of Alaska Pollock (Theragra chalcogramma) Skin Collagen. 2016, Pubmed
Sun, Myocardial repair/remodelling following infarction: roles of local factors. 2009, Pubmed
Thomford, Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery. 2018, Pubmed
Tipnis, A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. 2000, Pubmed
Tortorella, Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives. 2018, Pubmed
Vázquez, Production of Fish Protein Hydrolysates from Scyliorhinus canicula Discards with Antihypertensive and Antioxidant Activities by Enzymatic Hydrolysis and Mathematical Optimization Using Response Surface Methodology. 2017, Pubmed
Vermeirssen, Bioavailability of angiotensin I converting enzyme inhibitory peptides. 2004, Pubmed
Wang, Isolation and identification of anti-proliferative peptides from Spirulina platensis using three-step hydrolysis. 2017, Pubmed
Westermann, Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure. 2008, Pubmed
Wijesekara, Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry. 2010, Pubmed
Wysocki, Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. 2010, Pubmed
Yokoyama, Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito. 1992, Pubmed
Yu, Identification and Molecular Docking Study of a Novel Angiotensin-I Converting Enzyme Inhibitory Peptide Derived from Enzymatic Hydrolysates of Cyclina sinensis. 2018, Pubmed
Zaman, Drugs targeting the renin-angiotensin-aldosterone system. 2002, Pubmed
Zhao, A novel ACE inhibitory peptide isolated from Acaudina molpadioidea hydrolysate. 2009, Pubmed , Echinobase
Zheng, COVID-19 and the cardiovascular system. 2020, Pubmed
Zhou, HPEPDOCK: a web server for blind peptide-protein docking based on a hierarchical algorithm. 2018, Pubmed